Search research articles
Contact Us
Filters
Showing results (71-80 of 85) with videos related to
Page
of 9
Sort By:
Acta Neuropathologica Communications
|
April 22, 2026
Complement deposition, IgG subtyping and endplate destruction in LRP4-ab-positive myasthenia gravis
Sarah Hoffmann, Katharina Brokamp, Andreas Meisel, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
October 14, 2016
Stroke-induced immunodepression and dysphagia independently predict stroke-associated pneumonia - The PREDICT study
Sarah Hoffmann, Hendrik Harms, Lena Ulm, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
November 27, 2024
Ravulizumab and Efgartigimod in Myasthenia Gravis: A Real-World Study
Frauke Stascheit, Carla Daiane Ferreira de Sousa, Annette Aigner, et al.
Frontiers in Neurology
|
May 10, 2017
The Randomized Controlled STRAWINSKI Trial: Procalcitonin-Guided Antibiotic Therapy after Stroke
Lena Ulm, Sarah Hoffmann, Darius Nabavi, et al.
The New England Journal of Medicine
|
January 21, 2026
Efgartigimod for Fetal Acetylcholine Receptor Antibody-Related Disorder
Martijn R Tannemaat, Yvonne J M Campman, Bart Ballieux, et al.
The Journal of Rheumatology
|
October 1, 2022
Reliability of the Pediatric Specific Musculoskeletal Ultrasound Scoring Systems for the Elbow, Wrist, and Finger Joints
Patricia Vega-Fernandez, Ysabella Esteban, Edward Oberle, et al.
The Lancet. Neurology
|
January 25, 2025
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study
Carlo Antozzi, Tuan Vu, Sindhu Ramchandren, et al.
Journal of Neurology
|
September 27, 2022
Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis
Frauke Stascheit, Ulrike Grittner, Sarah Hoffmann, et al.
European Journal of Neurology
|
April 15, 2026
Complement Inhibition Therapy in Myasthenic Crisis-A Multicentre Retrospective Analysis of 17 Cases From Germany
Lea Gerischer, Maike Stein, Alice Schneider, et al.
Therapeutic Advances in Neurological Disorders
|
December 28, 2023
Guideline for the management of myasthenic syndromes
Heinz Wiendl, Angela Abicht, Andrew Chan, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 85) with videos related to
Sort By:
Page
of 9
Acta Neuropathologica Communications
|
April 22, 2026
Complement deposition, IgG subtyping and endplate destruction in LRP4-ab-positive myasthenia gravis
Sarah Hoffmann, Katharina Brokamp, Andreas Meisel, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
October 14, 2016
Stroke-induced immunodepression and dysphagia independently predict stroke-associated pneumonia - The PREDICT study
Sarah Hoffmann, Hendrik Harms, Lena Ulm, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
November 27, 2024
Ravulizumab and Efgartigimod in Myasthenia Gravis: A Real-World Study
Frauke Stascheit, Carla Daiane Ferreira de Sousa, Annette Aigner, et al.
Frontiers in Neurology
|
May 10, 2017
The Randomized Controlled STRAWINSKI Trial: Procalcitonin-Guided Antibiotic Therapy after Stroke
Lena Ulm, Sarah Hoffmann, Darius Nabavi, et al.
The New England Journal of Medicine
|
January 21, 2026
Efgartigimod for Fetal Acetylcholine Receptor Antibody-Related Disorder
Martijn R Tannemaat, Yvonne J M Campman, Bart Ballieux, et al.
The Journal of Rheumatology
|
October 1, 2022
Reliability of the Pediatric Specific Musculoskeletal Ultrasound Scoring Systems for the Elbow, Wrist, and Finger Joints
Patricia Vega-Fernandez, Ysabella Esteban, Edward Oberle, et al.
The Lancet. Neurology
|
January 25, 2025
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study
Carlo Antozzi, Tuan Vu, Sindhu Ramchandren, et al.
Journal of Neurology
|
September 27, 2022
Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis
Frauke Stascheit, Ulrike Grittner, Sarah Hoffmann, et al.
European Journal of Neurology
|
April 15, 2026
Complement Inhibition Therapy in Myasthenic Crisis-A Multicentre Retrospective Analysis of 17 Cases From Germany
Lea Gerischer, Maike Stein, Alice Schneider, et al.
Therapeutic Advances in Neurological Disorders
|
December 28, 2023
Guideline for the management of myasthenic syndromes
Heinz Wiendl, Angela Abicht, Andrew Chan, et al.
Page
of 9